Doctors & patients confirm acute shortage of the drug in hospitals, even as manufacturer Novartis maintains there is no ...

In a recent order, Oberoi Realty Limited and Novartis India Limited have been instructed to provide a clear title of a 15,241 ...

India serves as one of the key global hubs for development for Novartis. It leads the clinical development of potential new medicines, running clinical trials, and collecting evidence that turns ...

Swiss pharmaceutical company Novartis AG goes to India’s Supreme Court this week, to seek patent protection for its cancer drug, Gilvec. Lawyers will make their final arguments in an ...

Alcon, whose biggest market is the U.S. making up nearly a half of its revenue, said it expected annual net sales to grow by ...

Novartis India Q2 Results Live : Novartis India declared their Q2 results on 25 October 2024, reporting a topline increase of 10.59% year-over-year. However, the company faced challenges as profit ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on ...

New Delhi, Novartis India shares jumped more than 6 per cent on Monday after the parent company, Novartis AG announced a strategic review of its Indian arm. Novartis India was trading at Rs 1,100 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

View all information regarding the medicines that are manufactured by Novartis India Ltd. including its generic drug name, trade name, how to use, the price, and its composition. Aliskiren alone ...

Novartis India Ltd shares gained as much as 10.7 percent after parent Novartis AG said in a statement it will sell shares of its Indian unit via stock exchanges to reduce its holding. Advisory ...